Pfizer, Moderna raise prices for Covid-19 vaccines in European Union

[ad_1]

Inc and Moderna Inc have raised the prices of their Covid-19 vaccines in their latest supply contracts, the Financial Times reported on Sunday.


The new price for the shot was 19.50 euros ($23.15) against 15.50 euros previously, the newspaper said, citing portions of the contracts seen.





The price of a Moderna vaccine was $25.50 a dose, the contracts showed, up from about 19 euros in the first procurement deal but lower than the previously agreed $28.50 because the order had grown, the report said, citing one official close to the matter.


The terms of the deals —struck this year and covering up to 2.1 billion shots until 2023 —were renegotiated after Phase 3 clinical trial data showed vaccines from the two companies are more effective than some rivals, it said.


The European Commission said on Tuesday that the EU is on course to hit a target of fully vaccinating at least 70 per cent of the adult population by the end of the summer.


In May, the EU said it expects to have received more than a billion doses of vaccines by the end of September from four drugmakers.


and Moderna were not immediately available for comment to Reuters.


More nations that are a part of the block are making vaccination mandatory to access social life with ease.


France recently witnessed widespread demonstrations against what the people saw as a form of dictatorship. Germany’s government was also set to recommend the vaccine for all 12- to 17-year-olds on Monday, the Associated Press reported, citing a draft resolution ahead of a planned meeting of state-level health ministers.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor



[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *